ReAlta Life Sciences Inc., a clinical-stage biopharmaceutical company focused on safely targeting neutrophils and central ...

Good morning, and welcome to Ocugen's Webcast to discuss the Top Line 12-month Results from Phase II ArMaDa Clinical Trial Evaluating OCU410 for Geographic Atrophy or GA Secondary to Dry Age-related ...

This milestone launches dapansutrile into Phase 2 clinical development for neurological conditions, expanding upon ongoing trials with dapansutrile in rheumatologic diseases (Phas ...

Brings more than 20 years of experience in investment banking advising biotech and other innovative growth companies on financial and corporate ...

The whole-body MRI machines whir, in conversation with the skeleton staring back at me on the computer screen. On a gray ...

Newron today announced its financial results and operational highlights for the business year ended Dec. 31, 2025, and ...

Foot pain is often overlooked until it begins to interfere with everyday life. Simple activities like walking, standing for ...

What are probiotics, and how are they beneficial to your body? Host of Bloom, Amber Freeman, joins scientific advisory board ...

Johnson and Johnson advances immuno oncology research through collaboration; Phase combination trial explores bispecific ...

Source: Harare moves to merge kombi associations – herald Remember Deketeke Herald Correspondent HARARE City Council is finalising a major overhaul of the capital’s commuter omnibus sector that will ...

Presentations showcase progress in BioNTech's late-stage lung cancer programs, reinforcing the potential of the Company's differentiated portfolio spanning immunomodulators, antibody-drug conjugates, ...

Delivers revenue and profit within guidance Maintains consistent full year outlook Strong momentum in iX Suite enterprise wins NEWARK, Calif., ...